Beta Drugs Ratios and Metrics

Market cap in millions INR. Fiscal year is April - March.

Millions INR. Fiscal year is Apr - Mar.

Fiscal Year	Current	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Jul '26 Jul 30, 2026	Mar '26 Mar 31, 2026	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022
Market Capitalization	22,530	12,005	19,235	11,861	6,027	5,437
Market Cap Growth	31.40%	-37.59%	62.17%	96.79%	10.87%	423.79%
Enterprise Value	22,760	12,237	19,147	11,782	6,023	5,446
Last Close Price	2231.90	1189.30	1905.50	1175.00	597.10	538.57
PE Ratio	50.37	28.94	45.35	32.55	19.62	21.90
PS Ratio	5.49	3.12	5.31	4.01	2.65	2.96
PB Ratio	9.20	4.91	9.76	7.55	4.91	5.89
P/TBV Ratio	9.59	5.11	10.20	7.82	5.10	6.17
P/FCF Ratio	-	-	-	61.41	116.57	53.30
P/OCF Ratio	60.42	32.20	53.22	38.35	25.78	18.35
EV/Sales Ratio	5.55	3.18	5.28	3.98	2.65	2.96
EV/EBITDA Ratio	27.04	16.17	26.06	19.67	11.27	12.75
EV/EBIT Ratio	34.71	20.91	30.84	23.50	14.00	15.37
EV/FCF Ratio	-	-	-	61.00	116.49	53.39
Debt / Equity Ratio	0.60	0.60	0.70	0.09	0.17	0.22
Debt / EBITDA Ratio	1.76	1.95	1.88	0.25	0.38	0.48
Debt / FCF Ratio	-	-	-	0.76	3.93	2.02
Net Debt / Equity Ratio	0.09	0.09	-0.05	-0.09	0.01	0.04
Net Debt / EBITDA Ratio	0.27	0.30	-0.12	-0.23	0.02	0.08
Net Debt / FCF Ratio	-	-1.42	12.56	-0.72	0.23	0.32
Asset Turnover	-	0.83	1.05	1.31	1.27	1.34
Inventory Turnover	-	2.55	3.88	4.51	4.88	5.83
Quick Ratio	-	2.26	2.54	1.42	1.43	1.42
Current Ratio	-	3.10	3.22	2.10	2.03	1.98
Return on Equity (ROE)	-	18.78%	23.95%	26.03%	28.54%	30.85%
Return on Assets (ROA)	-	7.85%	11.24%	13.85%	15.10%	16.09%
Return on Invested Capital (ROIC)	18.64%	19.58%	27.91%	28.04%	29.31%	29.96%
Return on Capital Employed (ROCE)	-	15.10%	18.60%	29.60%	31.80%	32.60%
Earnings Yield	2.02%	3.45%	2.21%	3.07%	5.10%	4.57%
FCF Yield	-0.72%	-1.35%	-0.04%	1.63%	0.86%	1.88%
Buyback Yield / Dilution	-1.91%	-0.43%	-5.00%	4.76%	-	-